Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1996 Oct;5(5):341–345. doi: 10.1155/S096293519600049X

Degranulation of rat omental mast cells by A1 receptor agonists in vitro

A M Northover 1,✉, B J Northover 1
PMCID: PMC2365807  PMID: 18475728

Abstract

The haemodynamic effects of adenosine are thought to result in part from a release of mast cell amines via A3 receptor stimulation. To investigate the nature of the receptors involved in adenosine-induced mast cell degranulation in the rat isolated omentum we have used adenosine analogues with varying specificities as activators of the A1, A2 and A3 receptors, and antagonists with differing specificities for A1 and A2 receptors. Analogues which act predominantly as A1 (e.g. N6-cyclopentyladenosine) or as mixed A1/A2 receptor agonists (e.g. adenosine, inosine, 5'-(Nethylcarboxamido) adenosine) caused mast cell degranulation, whereas a predominantly A3 receptor agonist (IB-MECA) was inactive. Pre-treatment of the omentum with the A1/A2 receptor antagonist 8-phenyltheophylline or with the more specific A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine significantly reduced agonist-induced degranulation. Pre-treatment with disodium cromoglycate or with BN52021 also reduced degranulation of mast cells in response to N6-cyclopentyladenosine. In the rat isolated omental mast cell we conclude that degranulation is an indirect result of A1 receptor stimulation. Platelet-activating factor release appears to mediate at least part of the degranulation.

Full Text

The Full Text of this article is available as a PDF (478.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruns R. F., Fergus J. H., Badger E. W., Bristol J. A., Santay L. A., Hartman J. D., Hays S. J., Huang C. C. Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):59–63. doi: 10.1007/BF00165037. [DOI] [PubMed] [Google Scholar]
  2. Church M. K., Hughes P. J. Adenosine potentiates immunological histamine release from rat mast cells by a novel cyclic AMP-independent cell-surface action. Br J Pharmacol. 1985 May;85(1):3–5. doi: 10.1111/j.1476-5381.1985.tb08823.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Church M. K., Hughes P. J., Vardey C. J. Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br J Pharmacol. 1986 Jan;87(1):233–242. doi: 10.1111/j.1476-5381.1986.tb10176.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Daly J. W. Adenosine receptors: targets for future drugs. J Med Chem. 1982 Mar;25(3):197–207. doi: 10.1021/jm00345a001. [DOI] [PubMed] [Google Scholar]
  5. Doyle M. P., Linden J., Duling B. R. Nucleoside-induced arteriolar constriction: a mast cell-dependent response. Am J Physiol. 1994 May;266(5 Pt 2):H2042–H2050. doi: 10.1152/ajpheart.1994.266.5.H2042. [DOI] [PubMed] [Google Scholar]
  6. Fozard J. R., Pfannkuche H. J., Schuurman H. J. Mast cell degranulation following adenosine A3 receptor activation in rats. Eur J Pharmacol. 1996 Mar 18;298(3):293–297. doi: 10.1016/0014-2999(95)00822-5. [DOI] [PubMed] [Google Scholar]
  7. Gallo-Rodriguez C., Ji X. D., Melman N., Siegman B. D., Sanders L. H., Orlina J., Fischer B., Pu Q., Olah M. E., van Galen P. J. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists. J Med Chem. 1994 Mar 4;37(5):636–646. doi: 10.1021/jm00031a014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hamilton H. W., Taylor M. D., Steffen R. P., Haleen S. J., Bruns R. F. Correlation of adenosine receptor affinities and cardiovascular activity. Life Sci. 1987 Nov 16;41(20):2295–2302. doi: 10.1016/0024-3205(87)90542-x. [DOI] [PubMed] [Google Scholar]
  9. Hannon J. P., Pfannkuche H. J., Fozard J. R. A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br J Pharmacol. 1995 Jul;115(6):945–952. doi: 10.1111/j.1476-5381.1995.tb15902.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kusner E. J., Dubnick B., Herzig D. J. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells. J Pharmacol Exp Ther. 1973 Jan;184(1):41–46. [PubMed] [Google Scholar]
  11. Leoutsakos A., Pearce F. L. The effect of adenosine and its analogues on cyclic AMP changes and histamine secretion from rat peritoneal mast cells stimulated by various ligands. Biochem Pharmacol. 1986 Apr 15;35(8):1373–1379. doi: 10.1016/0006-2952(86)90284-4. [DOI] [PubMed] [Google Scholar]
  12. Linden J. Structure and function of A1 adenosine receptors. FASEB J. 1991 Sep;5(12):2668–2676. doi: 10.1096/fasebj.5.12.1916091. [DOI] [PubMed] [Google Scholar]
  13. Lohse M. J., Maurer K., Gensheimer H. P., Schwabe U. Dual actions of adenosine on rat peritoneal mast cells. Naunyn Schmiedebergs Arch Pharmacol. 1987 May;335(5):555–560. doi: 10.1007/BF00169124. [DOI] [PubMed] [Google Scholar]
  14. Lohse M. J., Maurer K., Klotz K. N., Schwabe U. Synergistic effects of calcium-mobilizing agents and adenosine on histamine release from rat peritoneal mast cells. Br J Pharmacol. 1989 Dec;98(4):1392–1398. doi: 10.1111/j.1476-5381.1989.tb12689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Marquardt D. L., Parker C. W., Sullivan T. J. Potentiation of mast cell mediator release by adenosine. J Immunol. 1978 Mar;120(3):871–878. [PubMed] [Google Scholar]
  16. Marquardt D. L., Wasserman S. I. [3H]Adenosine binding to rat mast cells--pharmacologic and functional characterization. Agents Actions. 1985 Sep;16(6):453–461. doi: 10.1007/BF01983646. [DOI] [PubMed] [Google Scholar]
  17. McNeil H. P. The mast cell and inflammation. Aust N Z J Med. 1996 Apr;26(2):216–225. doi: 10.1111/j.1445-5994.1996.tb00887.x. [DOI] [PubMed] [Google Scholar]
  18. Orr T. S., Hall D. E., Gwilliam J. M., Cox O. S. The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48-80. Life Sci I. 1971 Jul 15;10(14):805–812. doi: 10.1016/0024-3205(71)90035-x. [DOI] [PubMed] [Google Scholar]
  19. Ramkumar V., Stiles G. L., Beaven M. A., Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem. 1993 Aug 15;268(23):16887–16890. [PubMed] [Google Scholar]
  20. Richards I. M., Dixon M., Jackson D. M., Vendy K. Alternative modes of action of sodium cromoglycate. Agents Actions. 1986 Jun;18(3-4):294–300. doi: 10.1007/BF01964987. [DOI] [PubMed] [Google Scholar]
  21. Shepherd R. K., Linden J., Duling B. R. Adenosine-induced vasoconstriction in vivo. Role of the mast cell and A3 adenosine receptor. Circ Res. 1996 Apr;78(4):627–634. doi: 10.1161/01.res.78.4.627. [DOI] [PubMed] [Google Scholar]
  22. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES